RNA, U6 small nuclear 1152, pseudogene (RNU6-1152P)

RNU6-1152P is a processed pseudogene in the human genome, derived from the U6 small nuclear RNA (snRNA) gene family[2][4]. U6 snRNA itself is a highly conserved noncoding RNA that forms part of the spliceosome, which catalyzes pre-mRNA splicing in eukaryotic cells[1][3]. However, the "RNA, U6 small nuclear 1152, pseudogene" is a nonfunctional DNA sequence generated via L1 retrotransposon-mediated reverse transcription and integration[4]. Pseudogenes like RNU6-1152P do not produce functional RNA or protein and are not considered therapeutic targets nor involved in known disease processes[2][4]. Their presence in the genome, and diversity, primarily provides insight into retrotransposition mechanisms and genome evolution[4]. Summary of why this is not a therapeutic target: RNU6-1152P is a pseudogene and does not encode any functional RNA or protein. It is simply a genomic remnant derived from the U6 snRNA gene, lacking the capability to participate in spliceosome formation or any biological functions relevant to disease or therapy. Its status as a pseudogene excludes it from being a genuine "target" for drugs or biomarker use in clinical or research settings[2][4].

Other names

RNU6-1152PRNA, U6 small nuclear 1152, pseudogene

None (drugs do not target this pseudogene)